Charlotte's Web Holdings, Inc. (CWBHF)
OTCMKTS · Delayed Price · Currency is USD
0.0820
-0.0150 (-15.46%)
Dec 27, 2024, 4:00 PM EST

Charlotte's Web Holdings Company Description

Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products.

The company’s products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte’s Web, ReCreate, CBD Medic, CBD Clinic, and Harmony Hemp brands.

Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds.

The company distributes its products through retail outlets and health care practitioners, as well as online through its website.

It has a collaboration between its CW Labs science division and Colorado State University’s College of Agricultural Sciences; and scientific collaboration with McLean Hospital.

The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte’s Web Holdings, Inc. in July 2018.

The company was founded in 2013 and is headquartered in Louisville, Colorado.

Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings logo
Country Canada
Founded 2013
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 164
CEO William Morachnick

Contact Details

Address:
700 Tech Court
Louisville, British Columbia 80027
United States
Phone 720 484 8930
Website charlottesweb.com

Stock Details

Ticker Symbol CWBHF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
ISIN Number CA16106R1091
SIC Code 2834

Key Executives

Name Position
William J. Morachnick Chief Executive Officer and Non-Independent Director
Jared Stanley Co-Founder and Director
Erika Lind Chief Financial Officer
Raymond Kunkel Chief Operating Officer
Sarah Cambridge Corporate Controller and Chief Accounting Officer
Dr. Marcel Bonn-Miller Ph.D. Chief Scientific Officer
Greg Gould Chief Administration Officer
Cory Pala Director of Investor Relations
Stephen David Rogers J.D. Senior Vice President, General Counsel and ?Corporate Secretary.
Kelly Shea Senior Vice President of Government Affairs and Corporate Communications